Free Trial

Femasys (FEMY) Competitors

Femasys logo
$0.92 +0.08 (+8.84%)
As of 04:00 PM Eastern

FEMY vs. FONR, MGRM, NSPR, SRTS, INO, MLSS, VANI, CTCX, EDAP, and HYPR

Should you be buying Femasys stock or one of its competitors? The main competitors of Femasys include FONAR (FONR), Monogram Orthopaedics (MGRM), InspireMD (NSPR), Sensus Healthcare (SRTS), Inovio Pharmaceuticals (INO), Milestone Scientific (MLSS), Vivani Medical (VANI), Carmell (CTCX), Edap Tms (EDAP), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

Femasys vs. Its Competitors

Femasys (NASDAQ:FEMY) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership.

65.3% of Femasys shares are owned by institutional investors. Comparatively, 50.6% of FONAR shares are owned by institutional investors. 11.5% of Femasys shares are owned by insiders. Comparatively, 1.6% of FONAR shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Femasys has a beta of -2.62, indicating that its share price is 362% less volatile than the S&P 500. Comparatively, FONAR has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.

FONAR has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Femasys$1.70M13.91-$14.25M-$0.91-1.02
FONAR$103.02M0.87$10.57M$1.2511.60

In the previous week, Femasys and Femasys both had 5 articles in the media. Femasys' average media sentiment score of 0.74 beat FONAR's score of 0.63 indicating that Femasys is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Femasys
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
FONAR
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

FONAR received 142 more outperform votes than Femasys when rated by MarketBeat users. Likewise, 74.79% of users gave FONAR an outperform vote while only 73.58% of users gave Femasys an outperform vote.

CompanyUnderperformOutperform
FemasysOutperform Votes
39
73.58%
Underperform Votes
14
26.42%
FONAROutperform Votes
181
74.79%
Underperform Votes
61
25.21%

FONAR has a net margin of 7.68% compared to Femasys' net margin of -1,435.77%. FONAR's return on equity of 4.94% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
Femasys-1,435.77% -141.49% -82.30%
FONAR 7.68%4.94%3.70%

Femasys presently has a consensus target price of $8.67, suggesting a potential upside of 836.94%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than FONAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Femasys
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
FONAR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

FONAR beats Femasys on 10 of the 17 factors compared between the two stocks.

Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FEMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FEMY vs. The Competition

MetricFemasysSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$23.64M$4.37B$5.61B$8.62B
Dividend YieldN/A42.67%5.28%4.18%
P/E Ratio-1.1429.1227.1419.97
Price / Sales13.9170.72411.83157.64
Price / CashN/A51.0838.2534.64
Price / Book1.095.827.064.69
Net Income-$14.25M$67.63M$3.23B$248.14M
7 Day Performance15.63%0.35%2.67%2.39%
1 Month Performance-14.35%15.19%8.82%6.06%
1 Year Performance-11.06%17.92%31.44%13.57%

Femasys Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FEMY
Femasys
3.0959 of 5 stars
$0.93
+8.8%
$8.67
+836.9%
-21.3%$23.64M$1.70M-1.1430News Coverage
Analyst Forecast
FONR
FONAR
1.2937 of 5 stars
$14.50
flat
N/A-4.5%$89.94M$103.02M12.61480News Coverage
Positive News
Short Interest ↑
MGRM
Monogram Orthopaedics
3.0443 of 5 stars
$2.41
flat
$5.40
+124.1%
+21.7%$86.01M$365.00K-5.1328Positive News
NSPR
InspireMD
2.0668 of 5 stars
$2.54
-0.8%
$4.50
+77.2%
-8.6%$77.81M$7.03M-3.3950
SRTS
Sensus Healthcare
2.5043 of 5 stars
$4.72
-0.8%
$11.67
+147.2%
-10.5%$77.62M$39.49M11.8040Positive News
INO
Inovio Pharmaceuticals
4.0807 of 5 stars
$2.10
+5.0%
$9.75
+364.3%
-78.2%$77.02M$283.10K-0.66320Positive News
MLSS
Milestone Scientific
2.3097 of 5 stars
$0.95
+2.4%
$1.25
+32.3%
+22.1%$74.16M$8.61M-13.5030Short Interest ↑
VANI
Vivani Medical
2.6382 of 5 stars
$1.23
-2.4%
$4.00
+225.2%
-27.0%$72.87MN/A-2.7320News Coverage
CTCX
Carmell
N/A$3.30
-11.8%
N/A+19.9%$68.99M$32.84K0.0014News Coverage
Gap Up
EDAP
Edap Tms
2.2947 of 5 stars
$1.81
+1.8%
$8.50
+369.0%
-66.2%$67.77M$62.77M-2.79230Short Interest ↓
Analyst Revision
HYPR
Hyperfine
3.395 of 5 stars
$0.85
+41.1%
$1.06
+24.7%
-7.0%$66.16M$11.73M-1.49190Positive News
Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:FEMY) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners